A Endoscopic Ultrasound-guided Radiofrequency Ablation (EUS-RFA) Device Related Image
(Not Necessarily related to the device)
Description:
Habib EUS RFA by EMCISION LTD.
EMCISION LTD.'s Habib EUS RFA is a leading-edge medical device designed to deliver a minimally invasive endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) procedure. This groundbreaking tool is primarily used by healthcare professionals to treat both benign and malignant lesions in the pancreas and liver.
One of the key benefits of using the Habib EUS RFA is its innovative design and capability to perform precise ablations, thus reducing the risk of collateral damage to surrounding healthy tissues. This precision, combined with minimally invasive techniques, allows for a faster recovery and reduced hospital stay post-procedure.
Additionally, Habib EUS RFA has made significant strides in improving patient outcomes, reducing procedure-related complications, and enhancing the overall satisfaction of treating physicians. Its user-friendly design fits seamlessly with existing endoscopic ultrasound systems, enabling easy incorporation into a variety of clinical settings.
With consistent performance and high safety standards, the Habib EUS RFA by EMCISION LTD. serves as a state-of-the-art solution for the targeted treatment of pancreas and liver lesions, improving patient care and potentially increasing patient survival rates.
Primary Use:
Habib EUS RFA: A Premier Endoscopic Tool
Habib EUS RFA is a groundbreaking tool in the field of endoscopic procedures and has marked a significant development in minimally invasive treatments. As per its chief application, this device broadly facilitates the delivery of radiofrequency ablation (RFA) therapy using endoscopic ultrasound guidance.
Essentially, RFA is a popular form of tumor ablation technique that uses high frequency electrical energy to generate localized heat, which in turn helps destroy malignant or pre-malignant tissue. While this method is not new, the use of endoscopic ultrasound guidance, as enabled by the Habib EUS RFA, undoubtedly revolutionizes its implementation.
Radiofrequency Ablation via Endoscopic Ultrasound
The unique edge of the Habib EUS RFA lies in its enhancement of Radiofrequency Ablation therapy delivery. It facilitates the delivery of RFA through an endoscopic ultrasound, offering doctors unprecedented precision and safety in administering the treatment.
With the utilization of the endoscopic ultrasound, doctors now have the ability to visualize and access difficult-to-reach areas of the body. This instrument allows the physician to effectively treat lesions that are not easily accessible by percutaneous routes, and those that were previously deemed untreatable.
The Habib EUS RFA is a versatile tool that fits seamlessly into the standard endoscopic ultrasound, thus upholding a streamlined workflow. Furthermore, the tool is compatible with the standard 7 French (7Fr) biopsy needle guide thus making it a highly versatile and easily adaptable addition to the medical armory.
In conclusion, the Habib EUS RFA has revolutionized the landscape of minimally invasive internal treatments, with its superior capability to carry out Radiofrequency Ablation through endoscopic ultrasounds. This tool is indeed a testament to the progressive evolution in the medical field, offering physicians an efficient, precise and safer modality for tumor ablation.
How It Works:
Understanding the Habib EUS RFA Device
The Habib Endoscopic Ultrasound Radiofrequency Ablation (EUS RFA) device is an innovative piece of medical equipment under the category of Endoscopic Tools designed to facilitate therapeutic and diagnostic procedures.
Operating Mechanism
The fundamental driving technology behind the Habib EUS RFA device is the application of Radiofrequency Ablation (RFA). This involves harnessing radiofrequency energy to induce thermal damage and ultimately lead to cell death in targeted tissues.
EUS RFA employs a specialized flexible endoscope which features a high-frequency ultrasound probe providing physicians with real-time, high-resolution Ultrasound Imaging. This essential feature facilitates accurate placement of the RFA probe onto the targeted area, ensuring minimal collateral damage to surrounding healthy tissues.
Procedure and Application
Administering RFA through EUS involves the transmural deployment of an electrode, permitting direct visualization of the targeted site. This is accomplished by utilizing a patented stylet that deploys the RFA electrode from a 19G needle when in direct contact with the target site, ensuring correct delivery.
Primarily, the Habib EUS RFA is leveraged in treating various Pancreatic Disorders and Neuroendocrine Tumors. It has proven to be an effective tool in the palliative management of these conditions, offering a minimally invasive yet robust alternative to standard surgical interventions.
Safety and Efficacy
The Habib EUS RFA device exhibits excellent safety and efficacy profiles. The instrument features integrated safety measures to help manage potential adverse events effectively, such as the ability to control the intensity and duration of the radiofrequency application and an automated shut-off mechanism to prevent overheating.
In summary, the Habib EUS RFA device is an innovative instrument offering novel potentially curative therapeutic strategies for conditions which previously had a limited range of palliative treatment options. Its combination of precision, user control, and safety mechanisms underscores its utility and versatility as an essential tool in the modern endoscopic suite.
Manufacturer:
EMCISION LTD.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.